The Chemours Company provided earnings guidance for the year ending December 31, 2022. The company expects net income attributable to the company to be $810 million to $890 million, basic earnings per share of common stock to be $5.13 to $5.63 and diluted earnings per share of common stock to be $5.01 to $5.50.